Medtech giant Medtronic (Minneapolis) is set to boost its market share in the demineralized bone matrix (DBM) space by acquiring Osteotech (Eatontown, New Jersey) for $6.50 a share in cash, or about $123 million. The company plans to make the new acquisition part of its Medtronic Biologics (Memphis, Tennessee) business. (Medical Device Daily) Read More
